Obesity genes and the regulation of body fat content

BioEssays

Volumn 18, Issue 11, 1996, Pages 867-874

  Weigle, David S ^a,c   Kuijper, Joseph L ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b ZYMOGENETICS INC   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI; ANIMALIA; RODENTIA;

EID: 0030298083     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950181105     Document Type: Review

References (79)

1. Stunkard, A. J. et al. (1986). An adoption study of human obesity. N. Engl. J. Med. 314, 193-198.
2. Stunkard, A. J., Foch, T. T. and Hrubec, Z. (1986). A twin study of human obesity. JAMA 256, 51-54.
3. Cassidy, S. B. and Ledbetter, D. H. (1989). Prader-Willi syndrome. Neurol. Clin. 7, 37-54.
4. Price, R. A. and Stunkard, A. J. (1989). Commingling analysis of obesity in twins. Hum. Hered. 39, 121-135.
5. Jéquier, E. (1984). Energy expenditure in obesity. Clin. Endocrinol. Metab. 13, 563-580.
6. Leibel, R. L., Rosenbaum, M. and Hirsch, J. (1995). Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 332, 621-628.
7. Keys, A., Brozek, J., Hanschel, A., Mickelsen, O. and Taylor, H. L. (1950). The Biology of Human Starvation. University of Minnesota Press, Minneapolis.
8. Sims, E. A. H., Danforth, E., Jr., Norton, E. S., Bray, G. A., Glennon, J. A. and Salans, L. B. (1973). Endocrine and metabolic effects of experimental obesity in man. Rec. Prog. Hor. Res. 29, 457-496.
9. Roberts, S. B. et al. (1990). Energy expenditure and subsequent nutrient intakes in overfed young men. Am. J. Physiol. 259, R461-R469.
10. Stanley, B. G., Kyrkouli, S. E., Lampert, S. and Leibowitz, S. F. (1986). Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 7, 1189-1192.
11. Pijl, H. et al. (1993). Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans. Int. J. Obesity 17, 513-520.
12. Gibbs, J. and Smith, G. P. (1992). Effects of brain-gut peptides on satiety. In Obesity (ed. P. Björntorp and B. N. Brodoff), pp. 399-410. Lippincott, Philadelphia.
13. Kissileff, H. R., Pi-Sunyer, F. X., Thornton, J. and Smith, G. P. (1981). C-terminal octapeptide of cholecystokinin decreases food intake in man. Am. J. Clin. Nutr. 34, 154-160.
14. Lieverse, R. J. et al. (1993). Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism. J. Clin. Endocrinol. Metab. 76, 1495-1498.
15. Fujimoto, K., Fukagawa, K., Sakata, T and Tso, P. (1993). Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91, 1830-1833.
16. Weigle, D. S. (1994). Appetite and the regulation of body composition. FASEB J. 8, 302-310.
17. Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., and Porte, D., Jr. (1994). Insulin and the central regulation of energy balance: update 1994. Endocr Rev. 2, 109-113.
18. Weigle, D.S. (1988). Contribution of decreased body mass to diminished thermic effect of exercise in reduced-obese men. Int. J. Obesity 12, 567-578.
19. Weigle, D. S., Sande, K. J., Iverius, P.-H., Monsen, E. R. and Brunzell, J. D. (1988). Weight loss leads to a marked decrease in non-resting energy expenditure in ambulatory human subjects. Metabolism 37, 930-936.
20. Spraul, M., Anderson, E. A., Bogardus, C. and Ravussin, E. (1994). Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes 43, 191-196.
21. D'Alessio, D. A. et al. (1988). Thermic effect of food in lean and obese men. J. Clin. Invest. 81, 1781-1789.
22. Coleman, D. L. (1973). Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9, 294-298.
23. Coleman, D. L. and Hummel, K. P. (1969). Effects of parabiosis of normal with genetically diabetic mice. Am. J. Physiol. 217, 1298-1304.
24. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333, 352-354.
25. Warden, C. H. et al. (1995). Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J. Clin. Invest. 95, 1545-1552.
26. West, D. B., Waguespack, J., York, B., Goudey-Lefevre, J. and Price, R. A. (1994), Genetics of dietary obesity in AKR/JxSWR/J mice: Segregation of the trait and identification of a linked locus on chromosome 4. Mamm. Genome 5, 546-552.
27. West, D. B., Goudey-Lefevre, J., York, B. and Truett, G. E. (1994). Dietary obesity linked to genetic loci on chromosomes 9 and 15 in a polygenic mouse model. J. Clin. Invest. 94, 1410-1416.
28. West, D. B., Truett, G. E., Goudey-Lefevre, J. and York, B. (1995). Loci on chromosomes 4, 7, 9, 12 and 15 control a significant proportion of the dietary obesity phenotype in the mouse. FASEB J. 9, A722.
29. Bouchard, C. (1995). The genetics of obesity: from genetic epidemiology to molecular markers. Mol. Med. Today 1, 45-50.
30. Bultman, S. J., Michaud, E. J. and Woychik, R. P. (1992). Molecular characterization of the mouse agouti locus. Cell 71, 1195-1204.
31. Zhang, Y., Proenca, R., Mattel, M., Barone, M., Leopold, L. and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
32. Naggert, J. K. et al. (1995). Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat. Genet. 10, 135-142.
33. Noben-Trauth, K., Naggert, J. K., North, M. A. and Nishina, P. M. (1996). A candidate gene for the mouse mutation tubby. Nature 380, 534-538.
34. Chen, H. et al. (1996). Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491-495.
35. Lu, D. et al. (1994). Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802.
36. y) mutation. Proc. Natl Acad. Sci. USA 91, 2562-2566.
37. y) mutation explained by deletion of a maternally expressed gene and the simultaneous production of agouti fusion RNAs. Development 120, 1695-1708.
38. Duhl D. M., Vrieling, H., Miller, K. A., Wolff, G. L. and Barsh, G. S. (1994). Neomorphic agouti mutations in obese yellow mice. Nat. Genet. 8, 59-65.
39. Klebig, M. L., Wilkinson, J. E., Geisler, J. G. and Woychik, R. P. (1995). Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc. Natl Acad. Sci. USA 92, 4728-4732.
40. Zemel, M. B. et al. (1995). Agouti regulation of intracellular calcium: Role in the insulin resistance of viable yellow mice. Proc. Natl Acad. Sci. USA 92, 4733-4737.
41. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T. and Cone, R. D, (1992). The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
42. Moore, J. W., Willard, D., Moustaid, N., Wilkison, W. O. and Zemel, M. B. (1996). Role of intracellular calcium in agouti and insulin modulation of fatty acid synthase. FASEB J. 10, A187.
43. Kim, J. H., Mynatt, R., Moore, J. W., Woychik, R., Moustald, N. and Zemel, M. (1996). The effects of calcium channel blockade on agouti-induced obesity. FASEB J. 10, A186.
44. Manne, J., Argeson, A. C. and Siracusa, L. D. (1995). Mechanisms for the pleiotropic effects of the agouti gene. Proc. Natl Acad. Sci. USA 92, 4721-4724.
45. Mynatt, R. (1996). Analysis of the function of the agouti gene in obesity and diabetes. Proceedings of IBC Second Annual International Symposium: Obesity. Advances in Understanding and Treatment.
46. Kwon, H. Y. et al. (1994). Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc. Natl Acad. Sci. USA 91, 9760-9764.
47. Levy, J., Gavin, J. R., 3rd and Sowers, J. R. (1994). Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am. J. Med. 96, 260-273.
48. Porte, D., Jr. and Kahn, S. E. (1989). Hyperproinsulinemia and amyloid in NIDDM: Clues to the etiology of beta cell dysfunction. Diabetes 38, 1333-1336.
49. Birkeland, K. I., Torjesen, P. A., Eriksson, J., Vaaler, S. and Groop, L. (1994). Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia. Diabetes Care 17, 1307-1310.
50. Nickells, R. W., Schlamp, C. L., Newton, A. C. and Williams, D. S. (1993). Gene expression of the neuropeptide-processing enzyme carboxypeptidase E in rat photoreceptor cells. J. Neurochem. 61, 1891-1900.
51. Frederich, R. C. et al. (1995). Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96, 1658-1663.
52. Maffei, M. et al. (1995). Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc. Natl Acad. Sci. USA 92, 6957-6960.
53. Ogawa, Y. et al. (1995). Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J. Clin. Invest. 96, 1647-1652.
54. Hamilton, B. S., Paglia, D., Kwan, A. Y. M. and Deitel, M. (1995). Increased obese mRNA expression in omental fat cells from massively obese humans. Nat. Med. 1, 953-956.
55. Isse, N. et al. (1995). Structural organization and chromosomal assignment of the human obese gene. J. Biol. Chem. 270, 27728-27733.
56. He, Y., Chen, H., Quon, M. J. and Reitman, M. (1995). The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein a. J. Biol. Chem. 270, 28887-28891.
57. Rink, T. J. (1994). In search of a satiety factor. Nature 372, 406-407.
58. Weigle, D. S. et al. (1995). Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96, 2065-2070.
59. Rentsch, J., Levens, N. and Chlesl, M. (1995). Recombinant ob-gene product reduces food intake in fasted mice. Biochem. Biophys. Res. Commun. 214, 131-136.
60. Stephens, T. W. et al. (1995). The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530-532.
61. Pelleymounter, M. A. et al. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543.
62. Halaas, J. L. et al. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
63. Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R. and Burn, P. (1995). Recombinant mouse ob protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549.
64. Schwartz, M. W. et al. (1996). Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45, 531-535.
65. Tartaglia, L. A. et al. (1995). Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263-1271
66. Funahashi, T. et al. (1995). Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem. Biophys. Res. Commun. 211, 469-475.
67. Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B. and Flier, J. S. (1995). Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat. Med. 1, 1311-1314.
68. Maffei, M. et al. (1995). Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155-1161.
69. Saladin, R et al. (1995). Transient increase in obese gene expression after food intake or insulin administration. Nature 377, 527-529.
70. Cusin, I., Sainsbury, A., Doyle, P., Rohner-Jeanrenaud, F. and Jeanrenaud, B. (1995). The ob gene and insulin. A relationship leading to clues to understanding of obesity. Diabetes 44, 1467-1470.
71. De Vos, P., Saladin, R., Auwerx, J. and Staels, B. (1995). Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270, 15958-15961.
72. Considine, R. V. et al. (1995). Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95, 2986-2988.
73. Lönnqvist, F., Arner, P., Nordfors, L. and Schalling, M. (1995). Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med. 1, 950-953.
74. Considine, R. V. et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J Med. 334, 292-295.
75. Schwartz, M. W., Peskind, E., Raskind, M., Boyko, E. J. and Porte, D. Jr. (1996). Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Med. 2, 589-593.
76. Lee, G.-H. et al. (1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-635.
77. Chua, S. C. Jr. et al. (1996). Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor. Science 271, 994-996.
78. Cioffi, J. A. et al. (1996). Novel B219/ob receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. Nature Med. 2, 585-589.
79. Weigle, D. S. (1991). The pathophysiology of obesity: Implications for treatment. Endocrinologist 1, 385-392.